Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/83236
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?

AutorSlevin, Mark CSIC ORCID; Ahmed, Nessar; Wang, Qiuyu; McDowell, Garry; Badimón Maestro, Lina CSIC ORCID
Fecha de publicación30-abr-2012
EditorBioMed Central
CitaciónVascular Cell. 2012 Apr 30;4(1):9
ResumenAbstractNatural health products (NHP) which include minerals, vitamins and herbal remedies are not generally considered by medical practitioners as conventional medicines and as such are not frequently prescribed by health centre’s as either main-line or supplemental treatments. In the field of cardiovascular medicine, studies have shown that typically, less than half of patients suffering from coronary syndromes chose to take any form of NHP supplement and these products are rarely recommended by their medical practitioner. Vascular/endothelial cell damage is a key instigator of coronary arterial plaque development which often culminates in thrombosis and myocardial infarction (MI). Current treatment for patients known to be at risk of primary or secondary (MI) includes lipid lowering statins, anti-clotting agents (e.g. tissue plasminogen activator; tPA) and drugs for stabilization of blood pressure such as beta-blockers. However, evidence has been building which suggests that components of at least several NHP (e.g. aged garlic extract (AGExt), resveratrol and green tea extracts (GTE)) may have significant vascular protective effects through reduction of oxidative stress, lowering of blood pressure, reduction in platelet aggregation, vasodilation and inhibition of abnormal angiogenesis. Therefore, in this review we will discuss in detail the potential of these substances (chosen on the basis of their potency and complimentarity) as anti-atherosclerotic agents and the justification for their consideration as main-line additional supplements or prescriptions.
URIhttp://hdl.handle.net/10261/83236
Identificadoreshttp://dx.doi.org/10.1186/2045-824X-4-9
Aparece en las colecciones: (CIC) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
2045-824X-4-9.xml67,79 kBXMLVisualizar/Abrir
2045-824X-4-9.pdf600,67 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

Page view(s)

386
checked on 23-abr-2024

Download(s)

373
checked on 23-abr-2024

Google ScholarTM

Check


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.